Medicus Pharma (MDCX) Minority Interest (2025)

Medicus Pharma (MDCX) posted Minority Interest of $104865.0 for Q4 2025, little changed quarter-over-quarter from $105236.0 in Q3 2025.

Medicus Pharma (MDCX) Minority Interest (2025) Analysis & Trends

Medicus Pharma (MDCX) has reported Minority Interest for 1 consecutive years, with $104865.0 the latest figure, recorded in Q4 2025.

  • Minority Interest for Q4 2025 came in at $104865.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $104865.0 (changed N/A YoY), and the FY2025 annual result was $104865.0, changed N/A from the prior year.
  • Minority Interest was $104865.0 for Q4 2025 at Medicus Pharma, roughly flat from $105236.0 in the prior quarter.
  • Over five years, Minority Interest peaked at $105236.0 in Q3 2025 and troughed at $104865.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Medicus Pharma 6.91 Mn -1.69 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 104,865.00
Sep 30, 2025 105,236.00